Company news

United Therapeutics Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023

October 30, 2023

United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis

October 30, 2023

United Therapeutics to Acquire Miromatrix Medical

October 29, 2023

United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023

October 24, 2023

United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs

September 21, 2023

United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report

September 11, 2023

United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

August 31, 2023

United Therapeutics Corporation Reports Second Quarter 2023 Financial Results

August 1, 2023

United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023

July 25, 2023

United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

July 23, 2023

United Therapeutics Unveils Net Zero Energy Distribution Center

June 13, 2023

United Therapeutics Corporation Reports First Quarter 2023 Financial Results

May 2, 2023

United Therapeutics Corporation to Report First Quarter 2023 Financial Results Before the Market Opens on Wednesday, May 3, 2023

April 25, 2023

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings

April 17, 2023

United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 5, 2023

United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference

February 27, 2023

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results

February 21, 2023

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023

February 14, 2023

United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 1, 2023

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023

December 7, 2022

United Therapeutics Corporation Reports Third Quarter 2022 Financial Results

November 1, 2022

United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference

October 31, 2022

United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram Therapy

October 30, 2022

United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022

October 25, 2022

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting

October 13, 2022

United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis

October 10, 2022

United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit Report

September 11, 2022

United Therapeutics Prevails in Dry Powder Inhaler Patent Litigation

August 30, 2022

United Therapeutics to Feature Clinical Data at the European Society of Cardiology Congress 2022 and the European Respiratory Society International Congress 2022

August 23, 2022

United Therapeutics Corporation Reports Second Quarter 2022 Financial Results

August 2, 2022

United Therapeutics Corporation to Report Second Quarter 2022 Financial Results Before the Market Opens on Wednesday, August 3, 2022

July 26, 2022

United Therapeutics Provides an Update on Its Organ Printing Programs

June 5, 2022

United Therapeutics Corporation to Present at the Jefferies Healthcare Conference

June 2, 2022

United Therapeutics Announces FDA Approval of Tyvaso DPI™

May 23, 2022

United Therapeutics Corporation Reports First Quarter 2022 Financial Results

May 3, 2022

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the 2022 American Thoracic Society International Conference

April 28, 2022

United Therapeutics Corporation to Report First Quarter 2022 Financial Results Before the Market Opens on Wednesday, May 4, 2022

April 26, 2022

United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation

April 5, 2022

United Therapeutics Corporation to Present at the Oppenheimer 32nd Annual Healthcare Conference

March 7, 2022

United Therapeutics Corporation to Present at the Cowen 42nd Annual Health Care Conference

February 28, 2022

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results

February 23, 2022

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2021 Financial Results Before the Market Opens on Thursday, February 24, 2022

February 20, 2022

United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs

January 20, 2022

United Therapeutics Corporation to Webcast Executive Fireside Chat Conversation With J.P. Morgan Analyst

December 29, 2021

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022

December 2, 2021

United Therapeutics Corporation Reports Third Quarter 2021 Financial Results

November 2, 2021

United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference

October 31, 2021

United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021

October 26, 2021

3D Systems and United Therapeutics Announce Expansion of Bioprinting Program

October 26, 2021

United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021

October 20, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 22 decks. Every deck is listed under its year.